Viltepso IV infusion 250mg

Viltepso IV infusion 250mg, manufactured by Nippon Shinyaku, contains viltolarsen and is indicated for treating Duchenne muscular dystrophy (DMD) in patients with a confirmed DMD gene mutation amenable to exon 53 skipping. This 250mg 5mL 1 bottle formulation (YJ code: 1900400A1025) is an antisense oligonucleotide that helps produce a shorter but functional dystrophin protein, important for muscle function.